MDT

99.8

-0.46%↓

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

Kodu・Aktsiate loetelu・CorMedix Inc

CorMedix Inc

Suletud

SektorTervishoid

11.13 -1.24

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

10.91

Max

11.55

Põhinäitajad
By Trading Economics
Sissetulek	89M 109M
Müük	65M 104M
P/E Sektori keskmine	5.516 87.826
Kasumimarginaal	104.112
Töötajad	64
EBITDA	37M 57M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+55.42% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	24. märts 2026

Turustatistika
By TradingEconomics
Turukapital	92M 960M
Eelmine avamishind	12.37
Eelmine sulgemishind	11.13

Uudiste sentiment

By Acuity

58%

42%

314 / 372 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

9.2 / N/A Toetus ja vastupanu

CorMedix Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

7. jaan 2026, 23:11 UTC

Tulu

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7. jaan 2026, 22:55 UTC

Suurimad hinnamuutused turgudel

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7. jaan 2026, 21:39 UTC

Suurimad hinnamuutused turgudel

Raytheon Down Following Trump Post Criticizing Company

7. jaan 2026, 20:13 UTC

Suurimad hinnamuutused turgudel

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7. jaan 2026, 20:03 UTC

Suurimad hinnamuutused turgudel

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7. jaan 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7. jaan 2026, 23:46 UTC

Market Talk

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7. jaan 2026, 23:42 UTC

Omandamised, ülevõtmised, äriostud

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7. jaan 2026, 23:34 UTC

Market Talk

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7. jaan 2026, 23:29 UTC

Omandamised, ülevõtmised, äriostud

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7. jaan 2026, 22:48 UTC

Market Talk

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7. jaan 2026, 22:46 UTC

Tulu

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7. jaan 2026, 22:45 UTC

Tulu

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7. jaan 2026, 22:43 UTC

Omandamised, ülevõtmised, äriostud

Revolution Medicines Draws Takeover Interest -- 2nd Update

7. jaan 2026, 22:42 UTC

Tulu

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7. jaan 2026, 22:41 UTC

Tulu

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7. jaan 2026, 22:41 UTC

Tulu

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7. jaan 2026, 22:40 UTC

Suurimad hinnamuutused turgudel

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7. jaan 2026, 22:31 UTC

Market Talk

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7. jaan 2026, 22:22 UTC

Market Talk

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7. jaan 2026, 22:01 UTC

Market Talk

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7. jaan 2026, 21:46 UTC

Market Talk

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7. jaan 2026, 21:22 UTC

Omandamised, ülevõtmised, äriostud

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7. jaan 2026, 21:18 UTC

Omandamised, ülevõtmised, äriostud

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7. jaan 2026, 21:05 UTC

Omandamised, ülevõtmised, äriostud

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7. jaan 2026, 20:29 UTC

Omandamised, ülevõtmised, äriostud

AbbVie Near Deal for Revolution Medicines -- Update

7. jaan 2026, 20:27 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7. jaan 2026, 19:58 UTC

Market Talk

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7. jaan 2026, 19:48 UTC

Suurimad hinnamuutused turgudel

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Võrdlus sarnastega

Hinnamuutus

CorMedix Inc Prognoos

Hinnasiht

By TipRanks

55.42% tõus

12 kuu keskmine prognoos

Keskmine 17.5 USD 55.42%

Kõrge 22 USD

Madal 14 USD

Põhineb 6 Wall Streeti analüütiku instrumendi CorMedix Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

6 ratings

Osta

Hoia

Müü

Põhineb 6 analüütiku instrumendi CorMedix Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

9.2 / N/AToetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

314 / 372 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.